Corporate Banner
Satellite Banner
Technology Networks Header
Monday, November 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Simple and Sensitive Analysis of Vitamins in a Complex Nutritional Drink
Tuesday, April 22, 2014
Two-dimensional high-performance liquid chromatography method for determination of water-soluble vitamins.

Flow Meters Provide Valuable Data to Formula 1© Racing Teams
Thursday, April 17, 2014
Company designs a very lightweight oval gear flow meter to be installed in the racing car fuel tank.

Analysis of Pesticides Present in Ayurvedic Churna by GC-MS/MS
Saturday, April 12, 2014
A sensitive and precise assay for the detection of pesticides.

Procedure Management for Many Industries — Protocol Labacus 2.2 Announced
Monday, April 07, 2014
Software improves completeness, accuracy, efficiency and mobility for users and managers of standardized procedures and step-wise processes.

Bioo Scientific Launches AflaPure™ Aflatoxin Affinity Columns
Saturday, April 05, 2014
First commercial immunoaffinity columns designed to reduce cost of lab consumables.

Seward Ramps Up Stomacher® Bag Manufacturing
Friday, April 04, 2014
Minimizing delivery lead times and environmental footprint for ISO 14001.

Bosch to Showcase Complete Systems Competence
Thursday, April 03, 2014
Module++ lines for high adaptability, versatility and easy automation.

Bruker Launches Dash Reporting Software for GC-MS and LC-MS
Sunday, March 30, 2014
Software touted as the next step in intuitive customized reporting for routine, high throughput quantitative analyses.

Waters Redefines MS Performance With the ionKey/MS System
Sunday, March 30, 2014
Enhanced MS with the Turn of a Key

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 346
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv